KELLY HOOCK: Open Payments
NPI 1013660778 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 10 companies in 2025. Trend: 2023 $471 · 2024 $798 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $54 |
| Exact Sciences Corporation | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Organon LLC | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: Veozah, Kerendia, MOUNJARO, REXULTI, XIFAXAN, NEXPLANON, BREZTRI, Ozempic.
Industry payments across NM — which companies pay providers there.
